Evaluation of prognostic utility of topoisomerase IIand#593; MGMT KI 67 and P53 expression in pituitary tumors in a tertiary care hospital

Abstract

Abstract available newline

Description

Keywords

Citation

item.page.endorsement

item.page.review

item.page.supplemented

item.page.referenced